Concepedia

Qianshi Xu

QX

3

Publications

75

Citations

3

H-Index

2022

Active since

Affiliations

China Medical University(Current)

Northeastern University

Jiangsu Hengrui Medicine (China)

First Hospital of China Medical University

Anshan Hospital

Qianshi Xu is an author at China Medical University specializing in medicine, pharmacology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2022–2025

3

Publications

3

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

Nan Niu, Fang Qiu, Qianshi Xu et al. · Nature Communications · 2022 · 48 citations · Full text

, , +15

Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies

Chao Liu, Lisha Sun, Nan Niu et al. · Signal Transduction and Targeted Therapy · 2025 · 16 citations · Full text

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer

Shiwen Huo, Jinqi Xue, Shuo Wang et al. · MedComm · 2024 · 11 citations · Full text

Rows per page

1–3 of 3